EGFR and triple-negative breast carcinoma: It was reported that triple-negative breast cancer cells (MDA-MB-468) can produce exosomes with encapsulated EGFR (protected from EGFR inhibitor), which can induce EGFR signaling in target cells, thereby promoting cancer progression or resistance to therapy (99).